Perils of self-managed medical abortion: an observational study in aspirational district Fatehpur, Uttar Pradesh, India

Authors

  • Roshani Gupta
  • Pragya Shree
  • Divyata Sachan

Keywords:

Keywords: self-managed abortion, medical abortion, mifepristone, misoprostol, MTP Pill, MTP Act, maternal morbidity, India

Abstract

Background

Despite legislation governing medical termination of pregnancy (MTP), many women self-administer MTP pills

without medical supervision. This study aims to investigate the maternal morbidity and mortality associated with

the use of self-managed abortion pills and the various factors contributing to their misuse.

Methodology

We conducted a prospective, hospital-based observational study at Amar Shaheed Jodha Singh Attaiya Thakur

Dariyaon Singh Medical College, Fatehpur, Uttar Pradesh. Eligible women were consecutively enrolled during

routine clinical care between 1 July 2024 and 30 June 2025. Two hundred thirty-nine pregnant women who reported

to the outpatient department (OPD) or the emergency room with a history of taking the MTP pill (mifepristone–

misoprostol combination) without a valid medical prescription, whether procured by themselves or by another

person over the counter, were included in the study.

Results

Of 239 participants, most (76.15%) were aged 20–30 years. Over half (55.23%) were from rural areas, and 53.97%

belonged to the middle class. The majority (64.02%) had two or more children, and 61.51% had vaginal deliveries.

At the time of taking the MTP pill, 64.01% were under 12 weeks pregnant. Nearly one-third (31.80%) sought hospital

care more than 30 days after taking the pill. Severe anemia occurred in 21 participants, while 3 required ICU care, 3

developed sepsis, and 1 underwent laparotomy for ectopic pregnancy or perforation. No maternal deaths were

reported. Only 40.59% assessed their eligibility for medical abortion, and awareness of possible complications was

low (12.97%).

Conclusion

Using MTP pills without medical supervision can lead to severe and potentially life-threatening complications. It is

imperative to restrict easy and unrestricted access to these medications, necessitating the implementation of

stringent regulations targeting both individuals seeking the pills and those providing them.

 

Downloads

Published

2026-01-26